Patel Chirag K. 4
4 · Amneal Pharmaceuticals, Inc. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Patel Chirag K.
DirectorPresident & Co-CEO
Transactions
- Award
Performance-Based Restricted Stock Units
2024-03-04+1,333,334→ 1,333,334 total→ Class A Common Stock (1,333,334 underlying) - Award
Restricted Stock Units
2024-03-04+370,370→ 370,370 total→ Class A Common Stock (370,370 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on March 4, 2025.
- [F3]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F4]Represents a performance-based restricted stock unit grant of 666,667 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period.